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l. 
I. INTRODUCTICN 
A. Adrenergic Blocking Agents: The term "adrenergic blocking 
agent 11 includes drugs that are sympatholytic, that is, they prevent the 
effector cella from responding to adrenergic nerve impulses, and those 
that are adrenolytic, that is, they prevent the response to epinephrine. 
As a rule, these t"Vro properties are seen together. These drugs, in general, 
block only the stimulatory responses to epinephrine and not the inhibitory 
ones. 
The clinical applications of adrenergic blocking agents are as yet 
rather limited. They have proved useful in the diagnosis of pheochromo-
cytoma. They are employed clinically in cases of severe shock to cause a 
blockade of the exaggerated compensatory vasoconstriction (1). They are 
also given in cyclopropane -precipitated cardiac arrhythmias (1). 
At present, adrenergic blocking agents are of far greater value 
to the experimental investigator than they are to the clinician, since 
they are extremely useful in elucidating sympathetic functions in the body. 
B. Statement of Objectives: It was considered of value to teat an 
adrenergic blocking drug in an attempt to determine more closely the role 
of the sympathetic nervous system in sexual and reproductive functions. 
Experimental evidence is still incomplete as to the exact degree of parti-
cipation of this division of the nervous system in such mechanisms as the 
release of luteinizing h ormone from the pituitary and the path of t he ovula-
tory stimulus from t he genitals to the central nervous system. 
SY-21, N-ethyl-N (2-chloroethyl) 9 fluorenamine HCl, was the blocking 
agent chosen for t he study of some of t hese mechanisms, since it is knovm for 
ita potency and high specificity. 
2. 
II. THE ADRENERGIC BLOCKING AGENTS 
Aside from their common properties of adrenolysis and sympatholysis, 
adrenergic blocking agents may vary considerably. They are characteristic 
in that they block only excitatory adrenergic activity; the inhibitory 
components of epinephrine and adrenergic nerve stimulation are not blocked. 
The effects on the cardiovascular system are typical. The pressor 
response to epinephrine is blocked whereas the depressor response is not. 
The total effect, therefore, given by epinephrine in an animal treated 
with an adrenergic blocking agent is one of vasodepres sion - the so-called 
epinephrine 11reversal 11 • Some of these drugs, such as Dibenamine, (N, N-
dibenzyl- -chloroethylamine), also reverse the blood pressure response to 
stimulation of the splanchnic sympathetic nerves. This drug blocks sweating 
and. the pilomotor reflex, and causes myosis and ptosis. The chronotropic 
effect of epinephrine on the heart is not susceptible to blockade nor is 
the positive inotropic effect. 
Since adrenergic blocking agents do not interfere with the inhibi-
tory responses, sympathetic relaxation of the gastro-intestinal tract is 
not affected by these drugs. 
Blockade of metabolic processes varies with different drugs. Thus, 
Dibenamine, for example, does not block epinephrine hyperglycemia whereas 
ergotamine does. 
In choosing an adrenergic blocking agent for clinical purposes or 
for experimental use, the side eff ect of the drug greatly influences the 
choice. Priscol, for instance, aside from its adrenergic blocking activity 
also exhibits cholinergic and sympathomimetic eff ects and is therefore not 
suitable for all types of investigatior~. Ergotamine stimulates the smooth 
muscle of blood vessels, the uterus, and other organa, and also acts on 
the central nervous system. 
It has been observed that t he diff erent drugs exhibit varying de-
grees of antihistaminic activity (22).SY-28, N-(2-Bromoethyl)-N-ethyl-1 
naphthalene-methylamine • HBr is a very povterful antihistamine. Dibenamine 
and SY-21 are only weakly antihistaminic (22). 
As regards the mode of action of adrenergic blocking agents, it is 
believed that blockade is established at the effector cell itself. The 
drugs inhibit the response of this cell to epinephrine and epinephrine-
like substances. It is suggested that this eff ect is attributable to 
permeability changes in the cell (32). 
Certain analogies may be drawn between the action of these blocking 
agents and the action of atropine. It is believed that atropine also 
blocks a t the level of the effector cell. Both atropine and adrener gic 
blocking drugs selectively prevent the response of the effector cell to 
the specific chemical mediator - acetylcholine and epinephrine, respec-
tively, but do not prevent responses to unrelated chemical substances or 
to direct stimulation. Another similarity may be observed. Sympatho-
l ysis requires larger doses of the blocking agent than adrenolysis. In 
the ca se of atropine, small doses may prevent the depressor eff ect of in-
jected acetylcholine and block certain cholinergic responses without 
blocking the nervous effect on the urinary bla dder and the gastro-intestinal 
tract. 
Beta-haloalkylamines, syn~~ ic substances chemically rela ted to 
Dibe nam i ne, have been t ested for a drenergic blocking activity. Scree ning 
methods revealed t hat many of them ca n protect mice from letha l dose s of 
epinephrine(23). Among the active compounds, determined by t his technique 
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were l'J-benzohydryl-N-ethyl-f-chloroethylami ne-HCl, and N(IS( 2-biphe nylyloxy) 
ethyl~ N-ethyl-!-chloroethylamine HCl (23) . These compounds r eversed epi-
nephrine press or effe ct, and blocke d pressor responses to splanchnic stimu-
la t ion , anoxia, and car oti d occlusion. The latter two c ompot.mds a l s o 
exhibited antihistaminic activity. 
T\w other ha logena ted ethylamines a re kno\m to be rather pote nt 
adrener g ic blocking agents. They are SY-28 , N-(2-br omoethyl)-N-ethyl-1-
naphthalene-methylamine • RBr , and SY- 30 , N{2-( 2-biphenylyloxy ) ethyl_] 
- N-(2-chloroethyl ) butylamine• Hcl. SY-28 is also strongly a ntih istaminic, 
\'lhil e SY-30 is only -..reakly so .( 44 ). These two comp oLmds protected mice 
from letha l doses· of epinephrine . They Nere noted to reverse the e p i-
nephrine pressor response. In dogs , pressor responses to ni cotine and 
anoxia ;-;er e blocked and occa siona lly reversed. The carotid sinus reflex 
was diminished though not completely blocked. Both these substances are 
long- a cting comp ounds. The site of act ion bere is proba bly t he s ame a s 
for Dibenami ne, namely , at the effector cell (44). 
SY-21 
As stated above, the adrenergic blocking agent employed i n the ex-
periments reported in this paper was SY- 21, N-ethyl-N-(2 chloroethyl) 
9 rluorenamine HCl . TI1e chemical structure is outlined below. 
_,. C.W;r_-CLI3 
N-c~ -CJ-1 .. ~CI I ~ ... 
SY-21 has been found to potent adrenergic blocking agent . It 
is capable of protecting mice against lethal doses or epinephrine . 
SY- 21 is known to possess very weak antihistaminic activity. Since 
the dosage required to antagonize histamine is approximately 20 times 
that needed to block epinephrine (43) , as determined on the guinea pig 
seminal vesicle , the drug may be considered highly specific in its 
pharmacologic property. 
This high spe cificity along t.,rith a great potency led to the choice 
of SY- 21 in these experiments . 
6. 
III. REVIE\'f OF LITERATURE 
The question how LH release from the pituitary is controlled has 
received a great deal of attention, but proof of the true mechanism is 
still l a cking. 
It is well known that the stimulus reaches the pituitary by way of 
the hypothalamus. Fibers from the hypothalamus pass to the pituitary, 
but only a very few of them reach the adenohypophysis , (14). Anderson (1), 
in her review of the hypothalamus, indicates that moat, though not all of 
these fibers are o:r the sympathetic system. Green and Harris ( 12) de-
scribe fibers that reach the pituitary from the tuber cinerum and travel 
near the ves sels of the portal system in the median eminence and infundi-
bular stem. The mediation of a humoral agent has been suggested. Such 
an agent, according to Anderson (1), might be an autonomic mediator or 
even a hormone of the neurohypophysis. 
The role of the hypothalamus in sexual function is beet illustrated 
by clinical observations, since lesions in this area of the brain are fre-
quently associated with disorders of the reproductive system. Lesions of 
the hypothalamus may lead to cessation of menstruation or of potency. In 
some cases, atrophy of the gonads ac companies the disorder, but at times 
no histological changes are detectable. Some hypothalamic lesions cause 
overactivity of the gonads rather than loss of fUnction. The site and de-
gree of hypothalamic damage probably determine which disorder within this 
wide range of functional deviation ensues . (1) • 
There are even more numerous cases of gonadal disorders in which no 
organic disease can be demonstrated. Menstrual irregularity as well as 
impotence are often precipitated by fear, anxiety or mental strain. 
Although the neural mechanisms are but poorly understood, the inference 
7-
that the hypothalamus is involved seems justified (1). 
Hillarp (18) demonstrated interference of cyclic rhythmicity in 29 rats 
having lesions in t he hypothalamus produced by electrolys i s. Lesions were 
placed immediately lateral to the ventricular wall, below or caudal to 
the paraventricular nuclei. These rats went into a state of constant estrus. 
The ovaries contained follicles but no corpora lutea developed. The 
ovaries constantly reproduced estrogenic hormones as seen, too, by 
t he f act tha t t he uterus was thick and dilated. Only those lesions caused 
constant estrus that 1'/ere bilaterally symmetrical. The size of t he lesion 
was of little consequence as long as it was between t he paraventricular 
nucleus a nd t he hypophysea l stalk. 
Hillarp concluded from his findings that such lesions destroy the 
centers that control LH secretion from t he pituitary. The result of such 
destruction in t he hypothalamus, however, is one of reduction of LH secre-
tion - not a complete cessation. If LH release stopped, the ovaries could 
not continuously secrete estrogens, since such secr etion requires the co-
oper a tion of LH. Also, in the absence of LH, the interstitial cells would 
atrophy. 
All the above data suggest that there are discrete nuclei in the 
hypothalamus that are concerned with sexual function and, more specifically, 
with LH relea se f rom t he hypophysis. 
In view of the fa ct that t he stimulus to the pituitary to release 
LH comes f rom the hypothalamus, Markee, Sawyer, and Hollinshead (25) at-
te-1pted to induce such secretion by direct stimul ation of the hypothalamus. 
They 1vere able to reproduce hemorrhage in t he ovaries of 3 out of 4 rats 
by bipolar stimulation of the hypothalamus. Similar stimula tion of the 
8. 
of t he anterior hypophysis gave negative results in 7 animals. Ovula-
tion did~ occur in 6 out of 7 rata with unipolar stimulation of high 
voltage of the an terior hypophysis. Such stimula tion, however, was ac-
companied by a considerable spread of curre nt to adjacent areas. It 
seems possible that, in this aeries, t he hypothalamus itself received 
stimulation. It would appear, t herefore, that the pituitary cannot ini-
t i ate LH secretion in t he absence of a stimulus from the hypothalamus. 
Hany investigators have tried to determine the degree of partici-
pa tion of t he autonomic nervous system in LH release a nd ovulation. 
!.1ar kee, Sawyer, and Hollinshea d ( 25) found that electrical stimulation 
of the cervica l sympa thetic trunk or of the vagus did not result in 
ovula tion i n the rab bit. Brooks (3) described tha t sympa thectomy did 
not abolish coitus-induced ovula tion in the rabbit. Ovulation, in the 
r abbit, i n response to injections of pregna ncy-urine could still be 
elicited af ter sectioning the thoracolumbar and sacral fibers plus the 
vagus . (19). Haterius (16) found that in the rat sympathectomy did in-
hibit pseudopregnancy i n response to mechanical or electrical stimula-
tion, but did not inhibit t he response to sterile mating. This would 
ind i cate that the sympa thetic nervous system is not involved to the 
same extent in a physiological mode of s t i mulation as in an artificial 
one. One might suspect that electrical or mechanica l stimuli to the 
cervix do not constitute a true inde x of sympathetic participation in 
t he coitus-induced stimulus to t he hypophysis. 
Markee and co-workers ( 76), searching for autoJ»>nic mechanisms in 
ovulation, att e ~p ted to indu ce t his phenomenon by direct injection of 
a drenergic a nd cholinergic s ubstances in the rabbit. Acetylcholine 
(plus eserine), injected intravenously in a variety of doses, failed to 
produce ovulation. Injection of this drug into the a nterior pituitary 
in a dosage of approximately 25 micrograms produced one positive reaction 
in 30 rabbits. The authors poin t out that rabbits occasionally ovulate 
s p ontaneously a nd that this may have accounted for t he one positive re-
action in point. Intravenous doses of epinephrine, like acetylcholine, 
gave wholly negat ive results. Epinephrine administered directly into the 
anterior pituitary caused ovulation in 11 out of 71 animals. Here 120 
micrograms were given which constituted a rather large dose. The dr ug 
was tested in various dilutions of which 1:1000 proved the most successful 
and produced ovulation almost every time. 
It seemed possible that the action of epinephrine \-tas brought about 
by its eff ects on blood flow or metabolism. To rule out these reactions 
as a cause of ovulation, these workers studied two control aeries, ad-
ministering KClJ in the one and causing anoxia by carotid ligation in the 
other. No ovulation resulted from either procedure. They concluded that 
ovulation in the rabbit is an adrener gic phenomenon; they were still left 
in doubt whether normally the adrenergic compound is formed in the hypo-
thalamus or liberated directly within t h e pituitary by adrenergic fibers 
endi ng upon t he cells. Such fibers might arise either in the hypothalamus 
or in the superior cervical ganglion. Evidence against the latter is de-
monstrated by the fact that ovulation normally follo,.,.s copulation even 
after cervical sympathectomy. 
FUrther investigations regarding this autonomic link were undertaken 
by t he same group of workers, using adrenergic and cholinergic blocking 
agents. In 1947, Sawyer, Harkee, and Hollinshead (38) found that the 
adrenergic blocking drug Dibenamine could inhibit ovulation in the rabbit. 
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The dose employed ranged from 25 to 32 mg. per kg. and was administered 
i n travenously. Vfuen given within one minute after coitus, Dibenamine 
blocked ovulation in 16 out of 19 rabbits. If the injection was delayed 
three minutes or more after copula tion , no blockade ensued. It should be 
noted that 4 rabbits died of convulsions and many refused to ma te a f ter 
Dibenamine treatment. 
These reeul ts have been seriously questioned by Nickerson ( ?fJ) \'lho 
suggests that Sa'\'tyer 1 s observations may not have been caused by the anti-
a drenergic properties of Dibenamine but by other pharmacologic actions 
of this drug. Dibenamine ha s a direct excitatory influence on the central 
nervous system, an effect tha t is much faster in onset and shorter in 
duration than the adrener g ic blockade. :Maximum adrenergic bl ocking action 
does not occur until at least one and one-half hours after intravenous 
administration. Since Sawyer 1a experiments deal \'lith Dibenamine activity 
vd thin minutes after injection, Nickerson suggests that the observed 
results may very likely be effects of central ner vous system stimulation 
rather tha n of adrenergic blocka de. It is also pointed out tha t the 
blocking activity of Dibenamine is limited largely to smooth muscle and 
exocrine glands and has not been shown to block adrenergi c stimulation on 
the central nervous system. 
The suggestion was hence made to conduct control experiments using 
2-dibenzylaminoethanol, a hydrolysis product of Dibenamine '>lhich has no 
adrenergic blocking action but retains most other pharmacological proper-
ties of Dibenamine , including central nervous stimulation. 
sa,.,yer and his co-workers ( 36) proceeded to test this hypothesis, but 
found that 2-dibenzylaminoethanol , blocked ovulation in only 1 out of 10 
rabbits and i n none of 5 rata. 
11. 
It should be pointed out that the doses of' Dibenamine employed by 
Sa'l'ryer were as high as 32 mg. per kg. in many cases, and undoubtedly caused 
convulsions in many animals. Nickerson (30) reported that a dose of 50 mg. 
per kg. in mice was convulsive for all animals and lethal to 4o percent. 
Still further experiments by these investigators were designed to show 
that atropine can also block ovulation and LH release in the rabbit . (39). 
Blockade was seen more frequently if the drug was injected within seconds 
after coitus. Nhen 30 mg. per kg. were given within 10 to 4o seconds, 
69 percent of the 13 rabbits failed to ovulate. Later injections proved 
less successful. Blockade could also be produced by giving atropine 
before copulation. 
The authors compared the efficiency of blockade produced by atropine 
'l'ri th that of' Dibenamine. ','/hen given between 15 and 60 seconds post coitus, 
a tropine blocked 15 percent of' 20 rabbits whereas Dibenamine blocked 77 
percent of 13 animals. It was thought that the greater efficiency of 
Dibenamine might be attrj,butable to a faster onset of action. The authors 
tested this rate, using the pupil as a criterion. They found that the 
eff ect of atropine on the pupil commenced twenty-one seconds after injec-
tion, and was complete after thirty-two seconds. That of Dibenamine began 
at twenty-five seconds and was complete at thirty-five seconds. Thus, 
the onset of action could not account for the above results. The authors 
formulated the hypothesis that ovulation and LH release involve a choli-
nergic as well as an adrenergic component, the cholinergic one preceding 
the adrenergic one, at least in the rabbit. 
In these experiments, the investigators studied the a ppearance of 
the ovaries and uteri and found that atropine and Dibenamine exert no in-
fluence on luteal functions after the stimulus for LR release has reached 
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the adenohypophysis. That is, these drugs do not interfere \'lith the dis-
charge of LH or ita action on its target organa. It should be noted that 
t he same "Vtorkera (38) were unable to block ovulation in the rabbit with 
Priscol, a \iell-kno'm adrenergic blocking drug. The only explanation the 
authors off er is that though Priscol blocks epinephrine, t h is need not be 
the mediator involved in the ovulatory stimulus. 
It would appear from the above data that the evidence points strongly 
to a cholinerg ic link in addition to the adrenerg ic one. It must be re-
membered, however, that the doses of atropine used in this series are of 
entirely unphysiological proportions. \fuereas 5 mg. per kg. may be con-
sidered a rather l a rge intravenous dose, the amounts injected in these 
e xperiments are as great as 30 mg. per kg. 
Sawyer a nd his co-workers (10) carried out another group of experi-
me nts devised to establish more closely the time relationships between 
such cholinergic and adrenergic links in the ovulatory mechanism. The 
animals used were rats that exhibited regular four day cycles and were 
found to ovulate betv1een 1:00 and 2:30 A. M. of the day following proestrus. 
Criteria for ovulatory activity included not only the vaginal smear but 
a lso examina tion of t he oviduct for the presence of ova a n d examination 
of the ovary for cholesterol storage. Th is technique enabled the authors 
to recognize partial blockade of ovula tion. Dibenamine and atropine were 
e a ch tested at various hours on the day of proestrus and the degree of 
blockade evaluated. Their results led the authors to conclude that t he 
neurogenic i mpulse to the hypophysis to release LH takes pla ce between 
2:00 and 4: 00 P . H. on the day of proestrus. The time relationships were 
thus more clearly demonstrated. These \'lorkere expressed the belief that 
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the spontaneously ovulating animal has a 11 center 11 which exhibits in-
herent rhythmicity in its ovulatory stimulation. Changes may be super-
i mposed on this rhythm by such stimuli as light an d temperature altera-
tiona. 
Still further investigations were carried out with atropine and 
Dibe namine (35). This work was ba sed on t he generally accepted fact 
that in polyestrous animals, estrogen stimulates the release of LH from 
the pituitary. Evidence in the literature points to both the presence 
a nd the abse nce of a nervous mecha nism in this eff ect of estrogen. (2) 
Sa\"'yer att ributed this discrepancy to differences in operative tech-
nique an d suggested t ha t blocking agents would yield more uniform 
results t han nerve section. 
He therefore attempted to ascertain the ability of these drugs 
to block the estrogen stimulus to the pituitary in pregnant rats. \'/hen 
estrogen 1tfB S given on the f ourth day of pregnancy, followed by Dibenamine 
(30 mg. per kg. intravenously) on the fifth, ovulation occurred in 25 
percent of the rats and partial activation in another 25 percent. 
Estrogen alone gave a positive response in all animals. Atropine (700 mg. 
per kg. subcutaneously) following estrogen blocked ovulation completely 
in 80 percent of the animals and partially in the remaining 20 percent. 
\fuen LH itself was substituted for the estrogen, neither drug produced 
a ny blockade. 
Thus, both atropine and Dibenamine seem to inhibit the luteinizing 
eff ects of estrogen but not of LH. The authors take these rasults to 
indicate that neural mediation is probably involved in this action of 
estrogen. In a n attempt to fit t his effect into t he normal physiological 
picture, Sawyer advanced the theory that estrogen lowers the threshold 
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of a g onadotr ophic "se x cen ter" wh ich he believes is probably loca ted in 
the hyp othalamus. 
Everett and Sawyer (9) also found that the blocking drugs can a ffect 
the a ction of progesterone. This hormone, \oJhe n a dministered to the 
cyclic ra t, is capable of a dvancing ovula tion appr oximately t\'lenty-f'our 
hours . This effect v1as blocked by both the atr opine and Dibenamine. 
A mor e recent publi cation by the same v1orkers ( 37) tended to demon-
onstrate tha t atropine , besides blocking cholinergic activity, a lso protects 
against letha l doses of epinephrine. The writers raise the question a s 
to v1hether all their previous res ults v1ith atropine must be attributed to 
an antiadrener g ic potency of that drug. Such an explana tion a ppea rs 
highly i mprobable , especially i n view of' results obtai ned by Stone and 
Loew (45) wh o demonstrated t ha t a tr op ine d i d not s i gnifi cantly protect 
rabbits against letha l doses of epinephrine , though i t reduced pulmonary 
edema . Su e protection can hardly be attributed to a n a drener g ic 
blocking property of a t rop ine. 
I n c ontra st t o the data presented tha t suggest nervous me chanis~s, 
sta nds the work of Taubenhaus and Soskin (46 ) wh o ma inta i n that the 
pro ce s s is ma inly of a humoral na tur e. These workers injected a cetyl-
choline into t he pituitary of rats and found tha t pseudopregnancy ens ued 
in 13 ou t of 20 a nimals. Since t he se results obta ined even after the 
sta l k wa s severed, the.v \.vere led t o believe tha t nervo us elements v1ere 
not involved in this me chanism. 
In t he atte~pts t o elucidate the stimulus at the hypophysis involved 
in LH release , the r ole of t he pituitary stalk must of ne cessity be asses-
s e d. Impulses to t he g l and can be transmitted over t.he sta l k } a) via the 
nerves that travel from the hypothalamus to the neurohypophysis, and b) 
via the portal circulation. Stalk section affects both of these pathways, 
though the nerves proba bly regenerate to a greater degree than the ves sels. 
Green and Harris (12) found that fibers from the tuber cinerum end in 
proximity to the vessels of the portal system in the median eminence and 
the infundibular stem. 
Experiments using stalk-sectioned animals have been undertaken by 
various investigators. Brooks (3) found that section abolishes ovulation 
in the rabbit. Complete sympathectomy had no such inhibitory effects. 
Brooks relate d the effect on ovulation to nerve degeneration, observing 
that the nerve fibers entering the anterior lobe via the stalk were still 
present after sympathectomy but not a:rter stalk section. 
In 194o, Brooks and co-vtorkers (4) reported that ovulation in-
duced by pregnancy-urine in the rabbit still ensued after the stalk sec-
tion. (Some of the animals incurred injuries to the pars distalis; these 
rabbits needed larger doses of urine for ovulation). It appears then, 
tha t the ovaries, even after stalk section, retain their sensitivity to 
the ovulation-producing factor of pregnant urine. This is not true of 
the ovaries of hypophysectomized animals. 
Tne loss of ovulator y activity in stalk-sectioned rabbits was in-
terpreted by Haterius (17) as evidence that LH release from the pituitary 
is at least in part a nervous phenomenon. This hypothesis gained further 
support from his experiment in 1'lhich he transplanted guinea pig pitui-
taries to the eye, thus severing all nervous connections of the glands. 
These anima.ls went into constant estrus, lost their cyclic activity, 
and had no corpora lutea in their ovaries. In short, deprived of its 
nervous supply, the pituitary still liberates follicle stimulating 
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hormone but not LH. Haterius believed that since LH release is neural, 
at least in part, but not abolished by sympathectomy, the central nervous 
s ystem mus t be involved in ita control. 
Harris (15) at t emp ted to demonstrate t hat complete stalk section 
cannot produce uniformly predictable results, since the same degree of 
vascular regeneration does not always ensue. He- compared estrous regu-
larity in stalk-sectioned rats with the degree of regeneration and found 
them to be in direct correlation. Animals that lost cyclic rhythmicity 
completely showed little or no regeneration. Those that returned to 
normal cycles showed a marked degree of vascular reconstitution. In 
order to produce more uniform results, Harris sectioned the stalks of a 
group of animals and inserted foreign bodies - such as paper - between 
the cut ends. Using paper, only 1 out of 19 rats retained cyclic 
rhythmicity. 
In these rats, Harris again found a high degree of correlation 
bet'tleen regeneration of vessels and return of function. However, there 
appeared to be no correlation between function and the degree of atrophy 
of the pars distalis. 
These experiments thus tend to demonstrate the i mportance of 
humoral factors in LH release as transmitted over the portal circulation. 
It becomes appar ent then tha t the respective roles of humoral and 
nervous comp onents in the ovulatory mechanism have as yet not been de-
termined with definity and tha t further investigations leading to their 
elucidation would be of great help. In an att empt to contribute some 
more evidence towards the clarification of these problems, the fol-
lo.,Ting series of experiments were undertaken. 
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IV. EXPERTI<IENTAL STUDIES 
A. GENERAL ~mTHODS: All results presented in this paper were ob-
tained from 130 rate of the Sprague-rawley strain v1hich were three months 
old at the beginning of the experiment and eight months old at the termi-
nation. The animals were active and healthy with the exception of a very 
few which developed respiratory infections and were subsequently excluded 
from all experiments. 
The animals were kept three in a cage, separated by sexes, in an 
air-conditioned room, at a constant temperature of 80° Fahrenheit. An 
artificial twelve-hour day ( 8A. M. to 8P.M.) was regularly mainta i ned. 
The diet given was Steenbock 1 s standard diet (42) plus water ad 
libitum. The female rats consumed an average of 20 gm. of food a day, 
the males 30 gm. 
Vaginal smears were taken daily on all females during the entire 
course of the experiment. During the first three weeks, the animals 
were evalua ted for t he regularity of their estrous cycles; all rats with 
irregular cycles were excluded from further experimentation. At the 
end of the first three weeks of baseline studies, approximately half 
the colony (males and females) were put on the treatment diet until the 
end of the experiment. 
The drug SY-21, a white powder, was added into the diet for oral 
t herapy, at a concentration of 1 gm. of' drug per kilo of diet. To in-
sure uniform distribution, the drug was thoroughly mixed manually with 
casein, one of the ingredients of the Steenbock diet, and the casein 
then churned with t he remaining ingredients for one hour in an elec-
trical Hobart mixer. 
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An absolutely accurate measurement of the daily dosage adminis-
tered could not be made, but it is estimated that females ingested 15 mg. 
SY-21 a day, males 25 mg., or approximately 60 to 70 mg. per kg . per day. 
The rate \'tere weighed once a. we ek. Hean \'/eights of control and treated 
animals during the course of the experiment are given in Table I. A 
graphic representation is given in Figure 1. 
Animals that did not succumb in the course of the experiment, 
(as did some for blood pressure and weight studies) were killed at the 
termination; gross post mortem examinations were performed to detect 
the presence of any pathological changes. 
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B. ESTRUS AND OVULATION: Long and Evans, (24), in 1922, published 
the first comp lete description of the rat estrous cycle and the changes 
dependent upon ovulation. Their studies were based, to a large extent, 
on the · use of a newly found technique- the vaginal smear. 
This revolutionizing tool \'las developed by Papanicolaou ( 33), who 
in -121 discovered that cells from the vaginal contents give a reliable 
indication of the stage of t he feoale reproductive cycle. Today, the 
vaginal smear, with the aid of complex staining procedures, has become 
invaluable for fertility studies and cancer detection. 
Long and Evans found that the vagina changes radically during the 
estrous cycle, showing cornification during estrus, leukocytes in dies-
trus, and a combination of these and nucleated cells during the inter-
vening stages. They described the cycle as taking approximately four 
days, ovulation occurring during estrus or heat. Various stimuli were 
found to delay ovulation and produce what they termed pseudopregnancy. 
Corpora lutea of pseudopregnancy were found to be similar to those of 
normal ovulation and normal pregnancy. Corpora lutea of lactation, i.e., 
those produced during the first post partum estrus, have smaller lipoid 
granules. Before the onset of the next estrus, the granules again reach 
a normal size. The authors at t ributed these lipoid changes to the ter~ 
mina tion of the functional activity of the corpus luteum. 
The regularity of the estrou s cycle in the rat may be affected by 
certain external stimuli. The cycle may be markedly altered by exposing 
the animal to a dark and light environment that differs from the natural 
day-night succession. Browman (5) kept rats in light twenty-four hours 
a day and thus prolonged the cornified stage of the. vagina. Fiske ( 11) 
exposed rata to constant light from the twenty-first day of life and 
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f'o•.md tha t such animals matured considerably earlier than control rats. 
Ma turation ·Jas delayed in animals kept i n a constant dark environment . 
The ef'f'ect of cons t ant light was to enlarge the p ituitaries , (of' ma l e s 
a s vtell a s f'ema les), the ovaries, and the uteri . The author concluded 
that light stimula tes LH elaboration and decrea s es F. S. H. production. 
He yer and Heyer ( 29 ) were not able to duplicate a 11 these results . 
They exposed 16 rats to constant light and 16 to constant dark, from birth 
unt il the age of fifty days. They could find no alteration i n cyclic 
act ivity nor in pituitary weight. They found the adrenal glands en-
larged in both experimental group s . The sex organs 1-1e:re signif icantl y 
s maller i n the ani mal s exp osed to dark; no changes in those organs could 
be observed in animals ke p t in the ligh t. 
To prevent a ny possibl e influence of such environmental changes , 
the exp erimen-l:.s described below Here car ried out under strictly controlled 
light conditions . 
Several investigators , Rogers and All en ( 34) , Emery ( 8) , I a de and 
Do isey (47) , have re?orted a lterat ions i n t he appearance o~ the vagina 
follo1~ing prolonge d use o the vaginal smear te chnique . ''lade and Doisey 
produced epithelium of 12 or more l ayers in smeared rats as aga i nst 2 
l ayers i n contr ol ani mals. They we re ab l e to demonstrate , however , tha t 
such vaginal change s were no t acconpanie d by true e strous cha nge s in 
the uterus . 
Emery and Sch\~abe ( 8) reported to have produ ced p ositive (i.e ., 
estrous-like) vaginal smears in 30 percent to 50 per cent of a gr oup of 
castrated rats by 'l.leans of frequent s •t~abbing. In 1938 , t hey described 
that th is t e chni que not only cau ses prolif'erati on of the epithe lium, but 
also affects the submucosa which becomes edematous, hyperplastic, and 
inf'il trated Ni th leukocytes. Swabbing also appeared to increase the 
animals' sensitivity to theelin. 
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All these investigators procured vaginal smears by the use of a 
cotton swab. Smears were taken as often as f our times a day in some 
cases. In the experiment reported below, use of swabs was a voided; per-
sistent cornification did not occur even though smears were taken once 
daily for as long as t\tenty weeks . 
1. Methods 
Eighty-four female rats were used in this study. To rule out 
effects of' light, they were kept in an automatically controlled, window-
less room with artificial light from 8:00 A.M. to 8:00 P. H. 
Vaginal smears were procured in the following fashion. A common 
medicine dropper, having a curved tip 2 em. long and 2 mm. in diameter, 
was inserted gently into the vagina; 2 drops of' saline were expressed 
into the lumen, contents rinsed twice and then withdrawn. The 2 drops of' 
saline and vaginal cells were then placed on a slide a nd were studied, be-
fore drying and without staining, under a low-power objective. Smears 
were taken daily at approximately the same time, that is, between 12:30 
and 2:00 P. M. In evaluating t he smears, the following classification of' 
estrous cycle stages was made, (a slight modification from the nomenclature 
used by Long and Evans~. 
1. PROESTRUS - Small round cells with discrete nuclei predominate. Leuko-
cytes are rare. A few desquamated epithelial cells may be present. 
2. ESTRUS - The predominating cell is a large, flat, desquamated epithelial 
cell which lacks a nucleus. These cells are present in great numbers, often 
clumped together and obliterating any other cell form t hat may be present. 
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Examination of the smear with the naked eye reveals a typical granular, 
viscous appearance. 
3. METAESTRUS - A mixture of cellular elements is seen at this stage. Some 
desquamated, flat cella remain. Small, round, nucleated cells are present 
as are increasing numbers of leukocytes. 
4. DIESTRUS - This smear contains enormous numbers of leukocytes, closely 
packed together. Occasionally, a few nucleated round cells may be seen. 
On gross observation, t his smear gives a milky and very homogeneous ap-
pearance. 
It must be noted that the smears described above represent t he moat 
typical combination of cells for each stage. Since the vaginal epithelium 
is in a state of constant flux, many intermediary stages are encountered. 
Great care was taken to label each smear with the name of the stage it 
most closely approximated. 
In general, a normal rat showed estrus on the first day, metaestrua 
on t he second, diestrus on the third, and proestrus on the fourth day. 
However, since both metaeatrus and proestrus each last less than twenty-
four hours, they were not always observed in ea ch regular cycle. Estrus 
was frequently seen on two consecutive days, and diestrus \ofas at times re-
corded for three consecutive days in a normal animal. 
For three weeks, daily vaginal smears were taken on all 84 animals 
and t he regularity of their cycles evaluated. All rats shovdng poor 
regularity were discarded. The remaining animals (72 rate) were retained 
for the experiment. On the average, they exhibited regular four-day cycles 
with occasional five-day ones. Three and six-day cycles occurred but they 
were rare. 
At t he end of the three-week observation period, treatment with 
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SY-21 was begun in 36 of the 72 female rats. As stated above, this drug 
'Yta s mixed :i:nto the food a nd consumed at a dose level of approximately 70 
I mg.!J~.a day. All other factors were kept strictly identical for the control 
a nd treated rata. Therapy was continued until t he end of t he entire series 
of experiments or about four months. Daily smears (seven days a we ek ) 
were t aken during the twelve \'leeks following the onset of therapy. 
2. Results 
In the 36 treated rata the effects on cyclic rhythmicity con-
sisted es sentially of a marked irregularity, the cycle being prolonged in 
most ca ses. 
Of t he 36 animals, only 2 continued to have relatively normal cycles. 
The majority of the rats showed grossly irregular cycles, ranging from 
t hree to t welve days i n length. 
Ei ght animals showed one abnormally long anovulatory period lasting 
from eighteen to thirty-five days. 
Thirteen animals (33 percent) went into constant diestrus which 
lasted f or t he rema inder of the e xperimental period (except for 3 animals 
wh ich returned to rhythmicity after withdrawal of the drug). In these 13 
r ate, ovulation cea sed approximately two weeks after the onset of therapy. 
The effects of feeding SY-21 on the cycle length are summarized in 
Ta ble II. Since out of 36 treated rats, 13 were completely a novulatory, 
and 8 were so for several weeks, only the remaining 15 animals are in-
eluded in the data. Of the 36 control rate, 18 are arbitrarily included 
in the Table. Means were calculated by using the average of three con-
secutive cycles for each rat. 
Sta tistica l evaluation of the data revealed tha t t here v1as a signi-
Table I. }1ean Body '#eight of Treated and Untreated Hale and 
Female Rats During Seventeen \~eeks of Investigation. 
Mean Body ~'Ieight in Grams 
'leek Control Treated Control 
Females Females :Hales 
1 226 228 359 
2 232 230 365 
SY-21 started 
3 236 226 370 
4 237 213 384 
5 244 213 3)6 
6 245 221 ?95 
7 244 220 3)8 
8 254 224 3)0 
9 266 223 ?97 
10 269 232 4o4 
11 264 232 419 
12 261 227 418 
13 257 219 419 
14 256 224 420 
15 253 226 414 
16 251 232 401 
17 265 232 4o2 
Treated 
]Jfalea 
358 
359 
361 
346 
334 
337 
341 
328 
327 
313 
311 
317 
301 
316 
314 
311 
318 
1 
1(--- Onset of Treatment 
5 10 15 
TIME IN V.'EEKS 
Figure I. Mean Body Weight of Male and 
Female, Treated and Untreated Rats During 
Seventeen i1eeks of the Experiment. 
Treated Hales 
Control Females 
Treated Females 
Table II. Influence of Diet Containing SY-21 on 
Mean Estrous Cycle Length in the Rat. 
Time 
Before Treatment 
3rd and 4th \rfeek 
After Onae t of 
Treatment 
6th and 7th Y-leek 
After Onset of 
Treatment 
r'rean Cycle Length in Dayet Standard Deviation 
Control Rats 
(18 Animals) 
4.6~1.8 
Treated Rate 
(15 Animals) 
4.2 ! ·52 
7·53:3.64 
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f'icant difference (P < .01) between the cycles of the therapy group before 
treatment and after six weeks of treatment. The '1paired data 11 technique 
was used in this analysis. Comparison of cycles of' treated rata after 
six 'tTeeks of treatment with cycles of control rats during the same time 
interval also proved statistically significant, (P < .01). The 11 group mean 11 
technique was used in this analysis. 
It was observed that the treated animals consumed less food, starting 
soon after the onset of therapy. Food consumption dropped from approxi-
mately 20 gm. a day to 15 gm. in females and f'.rom 25 gm. to 20 gm. in 
males. The body \'Ieight \'Tas consequently aff ected as may be seen in Table I. 
During the first three weeks of therapy, the treated females lost an aver-
age of 17 gm. During this same interval, the control rats gained an 
average of 12 gm. \'lith time the difference in weight became obvious upon 
inspection, that is, the treated animals appeared smaller. At the end of 
the first seven weeks of the experimental period control animals gained an 
average of 34 gm. while the treated group showed little or no weight 
increase. 
Aside from the eff'ect .on weight and possibly appetite, no other changes 
were seen tha t could be attributed to SY-21. The treated rats were no more 
prone to respiratory infections than were the controls. SY-21 has been 
reported to cause gastro-intestinal irritation in the dog(43)1 The rat has 
no emesis mechanism, hence this reflex could not be observed. However, no 
other gastro~intestinal symptoms, ·· such as diarrhea coul d be observed at any 
time. The treated rats did not appear less active than the controls, but 
no quantitative studies were undertaken in this regard. 
3. Discussion 
It is apparent from the above data and analyses that therapy 
with SY-21 had a significant effect on the estrous rhythm of the cyclic 
rat. Ovulation ceased in a significant numer of animals and was post-
poned in almost all others. 
There is thus no doubt that the ovulatory mechanism was influenced, 
but the question remains whether this influence is a direct result of 
adrenergic blockade by SY-21. It is possible that the cyclic rhythmicity 
was disturbed by the loss of weight and a possible alteration of normal 
metabolic function. It should be noted here that the 3 treated, anovula-
tory rats, which were withdrawn from t herapy, became estrous after three, 
three, and six days respectively , a time interval during which little if 
any weight was gained. On the other hand, there were several non-treated 
animals which, for unknown reasons, lost weight; cyclic rhythmicity was 
in no way altered in these rata. It appears, therefore, t hat the dis-
turbance of the cycles of the treated animals is probably not a function 
of weight loss. 
It would be of interest to carry on further experiments to teat 
effect on ovulation by some drug that has the bitter taste a nd appetite-
decreasing effect of SY-21, without exhibiting adrenergic blockade. 
Quinine, for example, might be tried for this purpose. 
If it can be proved that it is the adrener gic blocking activity that 
delays or inhibits ovulation, the exact mechanism of action still re-
mains to be elucidated. The blockade may possibly exert ita effects 
on the hypothalamo-pituitary stimulus for LH release, since some evidence 
of an adrenergic component has been presented. 
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Direct in~luences o~ SY-21 on the ovaries should probably not be 
overlooked. It should be mentioned here that in 36 treated rats, ~our 
ovarian cysts and three tumors were noted. Controls showed no such dis-
or dera. 
c. PSEUDOPREGNANCY: The c~ndition known as pseudopregnancy was 
~irat described in the rat by Long and Evans ( 24 ). Pseudopregnancy is 
a state o~ simulated pregnancy in which all t he signs o~ pregnancy are 
duplicated except the actual presence o~ embryos. The most outstanding 
features of pseudopregnancy are a) the absence of ovulation~ and b) the 
consequent interruption of the normal estrous cycle. 
This induced state af fects all t he organs o~ the reproductive 
system. The vagina gives the appearance o~ diestrus throughout pseudo-
pregnancy, the smears consisting of leukocytes and scattered epithelial 
cells. Sections o~ the vagina show absence of cornification; the sur-
face cella are cuboidal or cylindrical. Vacuol ba t ion may be seen in 
the i ntermediary cell layers. These histological findings are typical 
of the true pregnant state but diff er from it in that they occur only 
in the upper portion of the vagina and in that they appear more slowly 
and do not progress beyond a stage typical of the tenth day of preg-
nancy. 
The outstanding change in the ovary is the loss of its cyclic 
rhythmicity, i.e., a complete cessat ion of ovulation. The last 
cor pora lutea - namely, t h ose produced during the estrus in which pseudo-
pregnancy was i ndu ced - persist, grow, and continue to function. They 
do not grow as fast as the corpora of gestation or lactation. Their 
lipoid granu les resemble those of t he corpora of ovulation and o~ pregnancy. 
But just before the end of pseu~opregnancy the granules increase in size 
and number and look like those of normal corpora, just before the onset of 
estrus. 
Long and Evans devised a method whereby they were able to prove that 
ovulation is suspended during pseudopregnancy. They injected a vital dye 
( Afr idol blue) into a pregnant anima).; soon after parturition, the animal 
was made pseudopregnant. After about fifteen days the animal was killed 
and the ovaries examined. Two sets of corpora lutea could be seen, the 
ones of pregnancy, (during which time all the old corpora degenerate), 
and those of pseudopregnancy. The former could be identified by the 
presence of the dye. Ovulation, therefore, had not occurred since the 
onset of pseudopregnancy. 
The corpus luteum of pseudopregnancy is like one of ovulation, 
partially transformed into one of pregnancy. The transformation is in-
complete because the factors acting later in pregnancy are absent here. 
Such factors probably arise in response to the stimulus created by the 
presence of the ova in the uterus and are hence not produced in pseudo-
pregnancy . ( 24). 
The effects of pseudopregnancy on the mammary gland are such as to 
enlarge it. According to some authors (44), milk can be expressed at 
the termination of pseudopregnancy - a phenomenon we could not reproduce 
in our eA~eriments. 
Pseudopregnancy may be produced by a variety of stimuli. l.fost 
techniques, however, are successful only if the stimulated animal is in 
estrus. 
The most physiological of such techniques is sterile mating. Long 
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and Evans induced pseudopregnancy in rats by mating normal males with 
females whose oviducts were occluded by infection. They obtained similar 
results by mating normal females with vasectomized males. Haterius (16), 
using the latter procedure produced pseudopregnancy in 96 percent of the 
females. 
In their preliminary att empts, Long and Evans found that injection 
of prosta te extract into the uterus via the cervical canals resulted in 
pseudopregnancy. They soon discovered that the same results were ob-
t.ained when Ringer 1 s solution was substituted for the extract and also 
vlhen a syringe was simply inserted without injection. 
They concluded tha t the activa ting factor was not the glandular 
e xtract but the mechanica l stimulation a nd henceforth used a simple glass 
rod to obtain t he desired results. They postulated that one purpose of 
t he vagina l plug, formed by male secretions a nd retained in the vagina, is 
to cause such stimulation. 
Acc ording to Haterius (16), the glass rod is not as efficient a 
stimulus as coitus; he wa s able to produce pseudopregnancy in onl y 47 
percent by the rod method. 
Several investigators have s uccessfully induced pseudopregnancy 
by electrica l stimulation of the uterine cervix. (20,28). The results 
of Haterius (16) . were 92 perce nt posit i ve, or a l most as high as by 
sterile ma t i ng. A similarly high percentage of positives was obtained 
by Shelesynak ( 40). It is of interest to note tha t in the ;..;ork of this 
author, applica tion of the electrodes without current never produced 
pseudopregnancy. One mi ght expect t hat this would cause a stimulus 
similar to the one produced by the glass rod. Al l these investigators 
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used A.C. current of 30 to 60 volts or an induced current from two dry 
cella. Stimulation was always carried out shortly before, during, or 
shortly after estrus. 
There are some pharmacological and hormonal agents which appear 
to be capable of producing pseudopregnancy. Copper acetate, given in-
travenously is reported to have induced this state in 100 percent of the 
rats tested . (7). It was found to be effective only on the day of estrus. 
When given in conjunction with estrogen, it acts at any stage of the 
cycle. However, it has also been observed that estrone alone produces 
pseudopregnancy when given during estrus. 
Collings induced pseudopregnancy with follutein in cats during 
"gammone 11 induced estrus . ( 6). 
One other method of pseudopregnancy production reported in the 
literature is one of direct central nervous system stimulation. 
Marshall and Verney (27) got positive results by stimulating the brain 
and also the lumbar cord electrically. 
l. Hethods 
In the experiments to be described, pseudopregnancy was in-
.duced by electrical stimulation of the uterine cervix. Only animals 
in full estrus were used for stimulation. 
The electrode employed consisted of two fine platinum wires encased 
in a smooth luci te rod of t he same dimensions as the medicine dropper 
used for vaginal smears, i.e., 2 rnrn. in diameter. The two stimulating 
wires were 2 mm. apart at the tip and emerged l mm. from the lucite 
casing. The current was supplied by two dry cell batteries connected 
to an inductorium. The voltage, as measured by the oscillograph, ,.,as 90. 
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No speculum was used in inserting the electrode into the vagina, but 
contact \-rith the cervix was ascertained in two ways. First, autopsies of 
several rats of the same group permitted accurate measurement of the dis-
tance from the exterior vaginal orifice to the openings of the cervical 
canals. As rats of each group were of approximately the same size, the 
distance was quite uniform in the autopsied rats and hence presumably 
also in the stimulated animals. Secondly, when the electr ode \-ras in-
serted the measured distance, slight resistance off ered by the cervix 
was felt. Thus the site of stimulation \-rae kept uniform in all animals. 
The rats were clamped down on a board especially constructed for 
this technique. Each animal received two shocks of three seconds each 
and spaced five minutes apart. The shocks invariably elicited a 
screeching and at times also a clonus in the hind limbs. Both reactions 
ceased immediately upon cessation of the current flow. 
Seventeen treated and 20 control rats received cervical stimulation. 
Since stimulation was carried out only on rats exhibiting estrus, none of 
the anovulatory animals of the treated group are respresented in this ex-
periment~ 
At the time these experiments were carried out, the r a ts had been 
on therapy for approximately seven weeks. 
2. Results 
It was arbitrarily decided that delay of estrus for seven or 
more days could be considered as a positive result in attempting to induce 
pseudopregnancy. Though different investigators have reported a great 
variety of figures for duration of pseudopregnancy; Slonaker (41) ob-
served a r ange of seven to nineteen days. It was hence considered 
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acceptable to include among positive results all cycles lasting seven days. 
The total number of pseudopregnancies induced was 18 out of 20 at-
tempted in the control group (or 90 percent) and 15 out of 17 att empts 
in the treated group (88 percent). 
In the treated animals, the prolonged cycle always followed im-
mediately upon stimulation. Of the controls, 7 animals exhibited one 
normal cycle before going into pseudopregnancy. (Greep and Hisaw (13) 
have reported similar results in their experiments.) 
The mean length of the cycles are summarized in Table III. Analyses 
are limited to those animals that gave positive results. rata of cycles 
before stimula tion are based on the average of the three cycles pre-
ceding pseudopregnancy. 
Table III. Mean Estrous Cycle Length of Control and Treated 
Rata Before and After Stimulation of the Uterine Cervix. 
Group Number of Mean Length of Cycle in Days Range of' Cycle 
Pseudopreg- ~ Standard Deviation. Length After 
nant Rata Stimulation 
Before Stimu- After Stimu-
lation lation 
Controls 18 4.61 ± 1. 8 10.0 ~ 2.05 7-14 
Treated 15 7· 5 "'!:.. 3. 6 13.0 ~ 3. 6 9- 22 
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The differences of the mean cycle length of the follo'tring observa-
tions were evaluated statistically. 
a. Control rata before and after stimulation P ( . 01. 
b. Treated rats before and after stimulation P ( . 01 . 
c. Controls before stimulation and treated rata before 
s t imu 1 at ion P '\ • 01. 
d. Controls after stimulation and treated rata after 
stimulation P < .01. 
Thus the differences were significant in each case. (Parts a and b were 
analyzed by the 11 paired data 11 technique, parts c and d by the 11 group 
mean 11 technique.) 
Electrical stimulation of the cervix, aside from inhibitory ovula-
tion and hence causing prolonged diestrus, also affected the body weight 
of the animals . Almost all pseudopregnant rata gained \'Ieight , the mean 
gain amounted to 12 gm. in the treated group and 18 gm. in the contr ole. 
During the same time interval, treated non-stimulated rata gained no 
\·teight and control non-stimulated rats gained an average of 3 gm. 
The amount of weight gained Na s too great to be explained solely by 
the distention of the uterus and the accumulation of fluid in the lumen. 
No other gross changes Nere observed that could be attributed to the 
pseudopregnant state. 
3. Discussion 
Electrical stimulation of the uterine cervix produced pseudo-
pregnancy in 90 percent of the controls and in 88 percent of the animals 
treated \vith SY-21. It a ppears from these data that adrenergic blockade 
does not interfere with the mechanism that induces pseudopregnancy as 
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a result of cervical stimulation. 
It is not known \·thether the stimulus to the pituitary inhibiting 
ovulation is of a nervous or humoral nature. The fact t hat sympathectomized 
animals failed to become pseudopregnant follo'tling cervical stimulation 
suggests that the stimulus is transmitted via the sympathetic chains. 
This hypothesis is strengthened still further by the observation t ha t 
anesthesia abolishes the pseudopregnancy response. (16A The fact that 
s ympathectomized animals do respond to infertile copulation does not 
necessarily argue against a nervous mechanism. Ha terius suggests that 
t he sexual excitement attending coition may act as a stimulus of a 
psychic nature. 
The present report is the first one dealing with the affects of 
adrenergic blocking agents on pseudopregnancy. As is well known, these 
drugs block neither all the effects of epinephrine nor a ll those of 
sympathetic nerve stimulation. In general, only excitatory responses 
are blocked and even among these there are exceptions. The failure of 
SY-21 to block pseudopregnancy may be due to a variety of factors. It 
may be that the stimulus arising from the genital region, though sympa-
thetic, does not respond to blockade, just as some other sympathetic 
responses escape blockade. It is also possible that the dose employed 
was not sufficient to inhibit the response. Or, it may be that other 
non-sympathetic factors are active in producing pseudopregnancy. FUrther 
experimentation is necessary for the elucidation of this mechanism. 
Although pseudopregnancy occurred in approximately the same per-
cent of rats in the treated and control groups , there \'las a significant 
diffe rence in the duration of the anestrous period in the two groups. 
Also, not only did pseudopregnancy last longer in the treated animals 
but it was also more variable in its duration, (as seen by the high 
standard deviation and large range). These results are not easily in-
terpreted, except t hat the longer pseudopregnant periods parallel the 
cycles before stimulation which were also significantly longer in the 
treated animals. 
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D. TRUE PREGNru~CY: It was considered of interest to teet the ef-
fects of the adrenergic blocking agent SY-21 on true pregnancy. Experi-
ments i-lere designed to teet the ability of treated male rats to fertilize 
control females, and of treated females to conceive and carry young 
to term. 
1. I>iethods 
Tv,ro series of mating experiments were undertaken. In the 
first, Series A, females were exposed to males at only one occasion, a 
period of approximately eighteen hours on the day of estrus. In the 
second, Series B, matinge were carried out for several days. In both 
series, three comb ina tiona were tested, namely: 1. Control females vd th 
control males. 2. Control females with treated males. 3. Treated fe-
males with control males. No attempts were made to observe that copu-
lation took place. 
In Series A, females that were in full estrus, as seen by the vaginal 
smear, were placed in a cage with one male from approximately 4:00 P. l•f. 
to 10:00 A. M. Since the two animals were not always on the same diet, 
food was withheld in all cases during the eighteen-hour period. All 
females were examined for vaginal plugs on the morning following mating. 
Since very few of the matings in Series A proved fertile, a second 
series (B) was undertaken. The animals were again placed together for 
eighteen-hour periods, this time, however, for several days (two to six), 
usually successive days. On each of the following mornings the females 
were examined for plugs and the vaginal smears were examined for the 
presence of sperm. As in Series A, food was withheld during the eighteen-
hour period. These experiments were carried out twelve to fifteen weeks 
after SY-21 therapy had been started. 
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2. Results 
The incidence of conception in the tested females of Series A 
and B is summarized in Table IV. 
Observations in Series A may be summarized. In group 1 (Control 
female, Control male), vaginal plugs were present only in the 2 females 
that conceived and subsequently carried to term. 
In group 2 (Control female, Treated male) no vaginal plugs \1ere seen 
and none of' the females conceived. 
In group 3 (Treated female, Control male) the 2 females that con-
ceived had not shown vaginal plugs after mating. 
Observations in Series B may be summarized. In group l (Control 
female, Control male) all 5 females s ho\1ed sperm on the smears on at 
least one occasion. Only one vaginal plug vtas noted, but 4 animals con-
ceive d. 
In group 2 (Control female, Treated male) l female showed sperm 
but another one conceived. No vaginal plugs were seen. 
In group 3 (Treated female, Control male) no plugs were seen. Two 
females showed sperm, one of which conceived. One other animal also con-
ceived. 
One of the treated females of' Series A died before term. One 
treated female of Series B was killed before term. Several rata, treated 
and controls, gave birth to stillborn litters • . In all cases, t he mother 
invariably devoured her young, so that further experiments on the off-
spring were not possible. 
Except for one treated rat which carried a single fetus, the 
litters ranged from 6 to 12, with no apparent difference between 
treated and control animals. The exact number of offspring, hovtever, 
Table IV. Incidence of Conception in Treated and Control Rats. 
Series A. Group Number of Pairs Number Conceived 
(1) Control Females 
with Control ~!alee 10 2 
(2) Control Females 
with Treated Malee 12 0 
( 3) Treated Females 
'tTi th Control 1viales 15 2 
Series B. Group Number of Number of Number Conceived 
Pairs :t-1a ti ngs 
(1) Control Females 
with Control Hales 5 17 4 
( 2) Control Females 
with Treated Males 6 10 1 
( 3) Treated Females 
with Control Males 10 27 2 
could not ah'lays be established \·lith certainty since many were devoured 
very soon after birth. 
The length of gestation varied £Tom about twenty-three to twenty-
six days, most frequently twenty-four, with no apparent difference in 
treated and control animals. There again, the exact number of days could 
not be established in every instance, since in those females that were 
mated on several occasions, the day of conception was questionable. 
Statistical analysis of the conception incidence data did not re-
veal any significant difference bet\'leen results in treated and control 
groups. 
3. Discussion 
The following generalizations may be made from the above ob-
servations. 
The treatment with SY-21 did not make it i mp ossible for a male to 
fertilize a normal female, as seen by one litter of young. Though this 
represents only one positive result out of a total of eighteen trials, 
it must be remembered that incidence of conception was also low in the 
untreated animals, (6 out of 15). 
The treatment with SY-21 did not make impossible fertilization, 
conception and normal pregnancy in treated females as seen by three 
litters that were carried to term. A fourth pregnancy occurred but 
proved lethal to the mother, but there is no proof regarding the role 
of the drug in this phenomenon. One can only say that treated animals 
can conceive, but it appears that conception may possibly occur lees 
frequently than in controls. 
It may be argued that conception may have taken place in some of 
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the animals, but that the embryos were resorbed or aborted due to some 
deficiency associated with the therapy. If the drug is responsible for 
reducing the number of fertile matings, the question arises whether its 
mode of a ction is to depress sexual factors leading to or active in 
copulation, or whether it interferes with the physiological mechanisms 
involved in fertilization, implanta tion and retention of embryos. 
E. BLOOD SUGAR: It is known that Dibenamine, SY-21, and various 
other adrenergic blocking agents will inhibit the hyperglycemic response 
to exogenous epinephrine , (21). There is some evidence that in the 
rabbit at least, epinephrine is released from the adrenal medulla at a 
continuous rate. Similar evidence is not available for the rat, the 
possibility nevertheless exists. If such is the case, an adequate dose 
of SY-21 might be expected to lower the resting blood sugar levels. 
Experime nts were therefore undertaken to teet for such alterations. 
1. :Methode 
Animals to be tested were fasted for twenty-four hours, re-
ceiving only water during t his period. Various methode for obtaining 
blood samples were attemp ted. 
In the rat, venipunctures are difficult, and cute at the tip of 
the tail clot "'i th great rapidity. It wa s found that the most efficient 
method wa s to tap the heart directly by puncture through the chest wall. 
All blood sugar determinations were made from samples obtained in this 
manner . The samples represented at times arterial and at times venous 
blood. Approximately .2 to .3 cc. of blood were withdrawn from each 
animal . One death res ulted from massive hemorrhage following cardiac 
puncture; t he rema ining a nimals exhibited no ill effects. 
The blood sugar was determined by the Folin-Malmrose micro-method, 
wh ich requires .1 cc. of blood. 
In t he treated group, 7 females and 6 males wer e tested. . In the 
control group, 6 fema les and 5 males were tested. 
These teats were done five weeks after the onset of therapy. 
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2. Results 
The mean blood sugar levels for control and treated rata are 
listed in Table v. 
In each group, the mean was higher f or the treated rata than for the 
controls. Statistical evaluation revealed that there was a significant 
diff erence in the blood sugar level of the treated females and control 
females, ( P ==.05), but not bet\.,reen treated and control males. The com-
bined sugars of males and females were significantly different in control 
and treated groups. 
3. Discussion 
It is apparent from the above data that SY-21, in the dosage 
administered did not cause a chronic lowering of the blood sugar. That 
is, if the a drenal medulla does release epinephrine in a continuous 
manner in these animals, SY-21 does not appear to decrease the hyper-
glycemic response to such secretion. However, speculation may lead to 
the hypothesis that in order to compensate for the depressing influence 
of the blocking agents, more epinephrine is released and maintains a 
normal blood sugar. 
The above data indicate in fact that the treated animals may have 
a somewhat higher blood sugar than the controls. It is entirely poe-
sible that SY-21 exerts some unknown metabolic influence that could ac-
count for the elevated blood suga r levels. 
Table v. ~1ean Fasting Blood Sugars of' Male and Female 
Rats with a nd without SY-21 
Group 
Control Females 
Control Males 
Combined Control 
Hales and Females 
Treated Females 
Treated Males 
Combined Treated 
and Females 
Hales 
Number of' 
Animals 
6 
5 
11 
7 
6 
13 
Mean Blood Sugars 
in l-ig./100 cc. 
113.2 ~ 8.7 
125.4 ~ 5 .2 
118.7 ~ 11.4 
127.4~ 15.2 
135· 7 ~ 12.1 
131.2 + 13.8 
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F. THE BLOOD PICTUHE : In studying the diverse effects of SY-21 
on the body, it \"las considered of interest to teat whether any a l tara tion 
of the blood picture occurred during therapy. 
The experiments were not directed at seeking out specific loci of 
action, (such as hemopoietic tissue or the blood cells proper), but 
rather to determine \vhether the drug causes any gross changes in the 
blood picture. 
1. ~-1ethods 
Animals used for this experiment were the identical ones 
used for t he blood sugar determinations. Blood for cell counts \vas ob-
tained from the same sample as that for the blood sugar experiment and 
hence represent heart blood samples of fasted animals. Determinations 
included total erythrocyte counts, total leukocyte counts, and differen-
tial leukocyte counts. A total of 24 animals were tested - 9 females 
a nd 3 males of both the treated and the control group. At the time 
of these tests, the treated animals had been receiving SY-21 for 
five v1eeks . 
2. Results 
Hean blood count values are listed in Table VI, i n addition 
to the statistical evaluation of the difference between the means. It 
can be seen that the treated group had a some'vlhat higher red count than 
did the controls. The mean total white count is almost identical in 
the two groups. The ratio of lymphocytes to granulocyte s appears very 
slightly higher in the treated animals but not significantly so. 
3. Discussion 
The only conclusion that may safely be drawn from the ab ove 
data is that SY-21, given in this particular dosage and route of 
TABLE VI. Mean Erythrocyte Counts, Leukocyte Counts, and Differential 
Counts of Jciale a nd Fema le Rats with and without Treatment with SY-21. 
Cells 
Rbc (in 
!Ullions 
Controls 
Treated 
\'lbc 
Controls 
Treated 
Granulocy tes 
( %) 
Controls 
Treated 
Lymphocytes 
( %) 
Con trols 
Treate d 
Number of Animals Mean Count 
't S.D. 
ll 6.09!'.62 
12 7.17!.45 
12 1 o, wot4, 89 2 
12 l0,53Ct2, 794 
11 16. 7'!:.7. 8 
12 14.6'!8.7 
11 81.3!7. 7 
12 84.5!8.8 
Range 
4.87-7.10 
6.47-8.53 
7,900-14,150 
6,700-15,650 
8-29 
3-32 
70-92 
66-93 
Significance of 
Differen ces 
P( .01 
(Significant) 
p >.5 
( Not signif ic ant ) 
p ).5 
( Not significant) 
p< ·4_,).3 
( Not significant) 
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administration, does not cause any gross depression of hematopoietic 
tissue or des t ruction of blood cells. It is rather questionable whether 
tl-;e increased number of erythrocytes observed in the trea ted rats may be 
interpreted t o represent a sc.imulus to the bone marr0\'1 for increased 
erythropoie sis. The number o:E' animals tested is too sma ll to warrant 
such conclusions. 
It ~night be sugge s ted tha t t he increa se in erythrocytes vta s due 
to a hemoconcentration of unknown cause. If such is the case , the 
total leukocyte count would also have to be increa sed. Indeed, the 
trend in the white count is in an upward direction, even though the rise 
is not statistically significant. Proof, ho\'lever, that hemoconcentr a tion 
ha s t a ken place, is lacking completely. 
G. ORGAN 1,·/EIGHT STUDIES: Associated \'lith the general and specific 
effects that SY-21 has on the body there are undoubtedly direct and in-
direct influences on the various organs. Such influences might be stimu-
latory in nature, with a possible hypertrophy of the organ; depression, 
on the other hand, might be accompanied by hypoplasia. 
In order to study the possible existence of such effects, it was 
deemed helpful to test for hyperplasia and hypoplasia in some of the 
endocrine and reproductive organs by determining the ratio of the 
11eight of the organ to the total body weight. 
1. Methods 
Eight treated females and 8 control females were killed by 
a blow on the head and four sets of organs were removed and weighed in 
the following manner. 
a) Both ovaries were removed; the oviducts vlith fimbria were 
not included in the weighing. Care was taken to remove all the sur-
rounding fat tissue, inflicting minimal damage to the follicles. 
b) Both uterine horns were dissected out and weighed. The 
uterus was severed proximally at the entrance of the ovarian tubes into 
the uterus proper; the distal cut was made at the junction of the 
cervical canals and the vagina. Care was taken not to express any of 
the fluid in the lumen of the uterine horns. 
c) Both adrenal glands were dissected out for weighing; the 
capsule was left intact and all surrounding connective tissue removed . 
d) The two lateral lobes of the thyroid were removed and 
weighed, but the isthmus was not included. No attempts \·tere made to 
separate the parathyroids from the thyroid gland. 
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Organs were removed and vreighed i mmedia tely after death. Blood a nd 
tissue fluids were blott ed off the outer surface of the organs. 
Only fema les in the diestrus phase were used in this experiment. 
At t he time of these tests, the treated animals ha d been receivi ng SY-21 
f or f our months. 
In t he statistical analysis of these measurements, organ weights 
are e xpressed as percent of total body weight. 
2. Results 
Results of t he experiment are summarized in Table VII. 
ileights of each group represent t he mean of 8 animals tested. 
As may be seen from Table VII, the thyroid glands 't/ere rela tively 
l arger in t he treated group, whereas the a drenals, ovaries, and uteri 
v;ere smaller, (the latt er tw·o not significantly so). 
As regards the uteri, it must be stated that, although all a nimals 
were in the diestrous stage, t he uterine fluid content was highly variable. 
This undoubtedly a ccounts f or t he high standard deviation. 
3. Discussion 
The fact tha t the reproductive organs a nd t he a drenals were 
some what smaller in the treated a nimals might be i nterpreted to indica te 
t ha t t he dr ug e xerted some type of depressing influence on these or gans. 
Wi t h respect to the ovaries, it must be pointed out tha t of the 8 
rats tested, 3 were completely a novulatory a nd 3 others had ovula ted 
onl y occasiona lly. These ovaries conta ined fe't/er and no doubt less 
a ctive follicles and less luteoid tissue. LH release from the pituitary 
was inhibited or decreased. In view of these facts, it is not sur-
prising t o find that t hese ovaries comprised a somewhat smaller fraction 
Organ 
Ovaries 
Uterus 
Adrenals 
Thyroid 
TABLE VII . Mean Organ i•Jeight to Body Weight Ratios 
of Treated and Control Female Rats. 
Mean Organ \'{eight to Body \Ieight Ratio 
in Percent '!: Standard Deviation 
Control Rats (8) Tr ea ted Rats ( 8 ) 
. 023 ± .004<3 • 020 t:". 0037 
• 164!..11 .1o8 :t_.o64 
.022:!:. . 0022 .019 :!::.· 0024* 
.oo67 .:!:. oon . 0084 !: .0017 
Significance 
of Differences 
p ).1 
P(. l, ). 05 
P>. Ol 1 (. 02 
P<. 01 
* In one of the 8 treated anima ls only one adrenal \-la s weighed and 
the r esult doubled. 
of the total body weight. 
These same animals had uteri that were less active and less developed. 
It became obvious upon inspection that the diff erence in weight between 
uteri from treated and untreated rats wa s not simply a function of fluid 
secretion in the lumen but mainly one of endometrial and myometrial 
structt~re. 
The effect of the drug on the adrenal is more difficult to inter-
pret in that t he weight of the gland includes two functionally diff erent 
entities - the cortex and the medulla - each of which may have been af-
fected in a different manner. The decreased size of the glands from 
rats treated with the drug may be taken to indicate a depressing or in-
hibiting influence of t he drug on these organa. However, in the absence 
of additional evidence, such an assumption cannot be considered well-
f'ounded. 
It is entirely conceivable that the lowered organ weight to body 
weight ratio observed is not attributable to any specific action of 
SY-21, but is simply a f'unction of generalized weight loss. The weight 
of the treated animals was identical with that of the controls at the 
ti~e t herapy was started. It is probable that the weight lose that a c-
companied t herapy did not progress unif'ormly in the various body tissues. 
The loss Nas undoubtedly minimal in the skeletal structure. The 
skeleton represents a considerable fraction of' the total body weight. 
_, \ 
Thence, a generalized lose of' weight may affect all the body tissues, 
except bone, quite uniformly and yet reduce the percent of total body 
weight contributed by any one given organ. 
The thyroids were found to be larger in the treated rats than in 
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the controls. If the suggestion regarding nonuniform weight loss, just 
advanced, actually holds true, than the increase in thyroid weight becomes 
even more significant than is apparent. The exact effect of SY-21 on this 
gland has not been studied. It may be suggested that the drug brings 
about some metabolic depression with a compensatory increase of thyroid 
activity. 
H. EPINEPHR i rm RE VERSAL: In order to demonstra te t he existence of 
adrenerg ic blockade i n the trea ted animals, attempts were ma de to show 
epinephrine reversal . 
Blood pressure was r ecorded f rom the carotid artery of t he anes-
t hetized ani mal, by i nser ting i nto t hat vessel a needle, connected to 
a mercury manometer, tr ansducer and viso-cardiett e. 
Attempts to demonstrate r eversal to intraperitoneal injections of 
100(' epinephrine gave variable results. Reversals were seen in t i'TO in-
stances but could not be reproduced. 
The technique '1'18 8 varied by giving epinephrine i ntravenously ( 2¥), 
to ani mals not previously tr eated, intraperitoneally and intrave nously. 
No clear-cut, reproducible reversals could be demonstrated. 
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V. SUJMARY AND CONCLUSIONS 
SY-21, administered to rats in an oral dose of ab out 70 mg./kg. a 
day over a period of several months, was found to give the follovling 
results. 
1. Estrous cycles v1ere significantly prolonged in all animals. 
Ovulation ceased completely in one-third of t he animals. It is sug-
gested that the drug interf'ered with the stimulus to the pituitary to 
release LH. This interference may well be due to a drener gic blockade, 
but other influences e xerted by SY-21 were not ruled out. 
2. Pseudopregnancy in response to electrical stimulation of the 
uterine cervix was not i nhibited by SY-21. The pseudopregnant interval 
was longer in the treated r a ts than in the controls. It is concluded 
the.t the drug does not interfere with the mechanism by which the 
stimulus from the genitals causes inhibition of ovulation. 
3. Treated female rats were able to conceive and carry fetuses . to 
t~rm. Treated male rats could i mpregnate control females. SY-21 did 
not abolish these responses. 
4. The blood sugar of trea t e d rats was found to be higher than 
that of the controls. If a constant f'low of epinephrine was secreted 
in these animals, raising the blood sugar , SY-21 did not block such 
hyperglycemi a . There is, however, no evidence or proof that such con-
tinuous secretion exists. 
5· The blood picture was essentially the same in both groups, 
though the trea ted rats showed a tendency towards elevated erythrocyte 
counts. The a ssumption that the marrow is stimulated to increased ery-
thropoiesis cannot be made f rom these limited observa tions. The possi-
bility of hemoconcentration was not ruled out. 
6. The adrenals of the treated female rate constituted a sma ller 
percent of the total body weight than did the organs of t h e control rata. 
The opposite was f ound to be true of .the thyroids. Stimul at ion and de-
press ion, respectively, by the drug, is suggested but in no way established. 
7. The general effe ct of SY-21 was such as to reduce the body \'Ie i ght 
significantly. It has not been established \thether t his effect was a func-
tion of reduced food i ntake onl y , or whether SY-21 exerted metabolic 
infl uences . 
III 
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